Skip to content

Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Primary Ciliary Dyskinesia

REproductive Health in PRimary Ciliary Dyskinesia: Developing User-informed Clinical and Educational Resources (REPRoDUCE)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07531277
Acronym
REPRoDUCE
Enrollment
30
Registered
2026-04-15
Start date
2026-04-01
Completion date
2029-03-31
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility, Health Information Exchange, Pregnancy, Primary Ciliary Dyskinesia (PCD)

Brief summary

This project will involve working with people with PCD and medical professionals to develop resources that will help patients and the people providing their care to better understand fertility and pregnancy safety in people with this condition.

Detailed description

The study investigators will co-develop an online educational animation and text resource for patients and the public about PCD and fertility and pregnancy. Development of patient resource: The study investigators will conduct workshops with a group of approximately ten people including additional PPI representatives (adults with lived experience of PCD), representatives from PCD Support UK and medical professionals specialising in PCD. In stage 1 of the resource development, the study investigators will conduct an online workshop to identify priorities for information for inclusion in the resource. In stage 2 the study investigators will create a resource prototype based on the information gained in stage 1. In stage 3 the study investigators will conduct and record 1:1 online think aloud interviews to capture real-time reactions and gain evaluation of the resource prototype to identify areas for improvement. In stage 4, the study investigators will make further resource modifications. In stage 5 the intervention will be tested in a sample of men and women with PCD (n=10). The study investigators will then conduct an online quiz to measure pre- and post- resource use knowledge about PCD, fertility and pregnancy, and collect suggestions for improvement via a survey form. Feedback from stage 5 will be incorporated into the final resource prior to dissemination. The resource will be translated into non-English languages spoken in the UK to aid inclusion of a wider audience. Co-development of toolkit for medical professionals: The study investigators will co-develop an online educational toolkit for medical professionals about fertility and pregnancy in patients with PCD. The study investigators will utilise the same group of approximately ten people including PPI representatives, representatives from PCD Support UK and medical professionals specialising in PCD as above. The study investigators will follow the above stages 1-4 for development of the toolkit. In stage 5, the study investigators will test the intervention in a sample of non-PCD specialists (n=10). During this stage an online quiz will be conducted to measure pre- and post- toolkit use knowledge about PCD, fertility and pregnancy, and collect suggestions for improvement via a survey form. Feedback from stage 5 will be incorporated into the final resource prior to dissemination.

Interventions

OTHEROnline educational resource

Co-developed educational resource for patients

OTHERToolkit for healthcare professionals

co-developed online educational toolkit for healthcare professionals

Sponsors

University of Southampton
Lead SponsorOTHER
University of Cardiff
CollaboratorUNKNOWN
University Hospital Southampton NHS Foundation Trust
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged 18 years or older 2. 'Highly likely' or confirmed diagnosis of Primary Ciliary dyskinesia, or being a healthcare professional, or representative from a stakeholder group e.g. patient led charity 3. Able to understand and willing to sign the informed participant consent prior to participation

Exclusion criteria

1. Unwilling to participate in the study 2. Not meeting inclusion criteria 3. Unable to understand or unwilling to sign the informed participant consent prior to participation

Design outcomes

Primary

MeasureTime frameDescription
A resource for patients and a toolkit for medical professionalsDuration of study (up to 3 years)1. Development of a resource for patients and toolkit for healthcare professionals 2. Qualitative and quantitive participant data on the acceptability and usefulness of above resources.

Contacts

CONTACTLydia Newman
Lydia.newman@soton.ac.uk+44 23 8120 6033
CONTACTYing Cheong
Y.Cheong@soton.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026